IP vs JAZZ · P/E 43, $26.62B cap vs P/E 1988, rev $4.07B
International Paper (IP) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
IP currently screens at market cap $26.62B and trailing P/E 43.1. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the IP and JAZZ stock pages for the full models.
Not investment advice.